@merz @jgordon @DeanBaker13 okay! i’m not really arguing one way or another about that (but no, i’m not taking your word, and i think you are largely wrong), but using public action to undermine regulatory moats that prevent already developed drugs from being marketed was the Dean’s proposal, which i continue very much to endorse.

@merz @jgordon @DeanBaker13 (to be clear, i don’t dispute that drug development is very difficult. but i do dispute there’s something special about its difficulty that means only institutions not so different from status quo private sector monopolists could perform it.)